Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of pantoprazole on sleep-related breathing disorders
2005-001497-27Phase 2Completed
- Sponsor
- Altana Pharma
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of pantoprazole in sleep disordered breathing (SDB) and gastroesophageal reflux disease (GERD), sponsored by Altana Pharma. Primary endpoint: Effect of pantoprazole on sleep-related breathing disorders. Started Jul 2005; status: completed.
02
Drugs
pantoprazole
03
Conditions
sleep disordered breathing (SDB)gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on 2005-001497-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001497-27.